NCT00084240View on ClinicalTrials.gov

Azithromycin Plus Chloroquine Versus Sulfadoxine-Pyrimethamine Plus Chloroquine For The Treatment Of Uncomplicated, Symptomatic Falciparum Malaria In Southeast Asia

PHASE2/PHASE3TerminatedINTERVENTIONAL

Enrollment

32

Participants

Timeline

Start Date

March 31, 2004

Study Completion Date

April 30, 2005

Conditions

Malaria, Falciparum

Interventions

DRUG

Azithromycin/Chloroquine

DRUG

Sulfadoxine-Pyrimethamine/Chloroquine

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Pfizer

INDUSTRY

NCT00084240 - Azithromycin Plus Chloroquine Versus Sulfadoxine-Pyrimethamine Plus Chloroquine For The Treatment Of Uncomplicated, Symptomatic Falciparum Malaria In Southeast Asia | Biotech Hunter | Biotech Hunter